Neuphoria Therapeutics, Inc. (NEUP)
3.73
0.00 (0.00%)
USD |
NASDAQ |
Sep 11, 16:00
3.74
+0.01
(+0.27%)
After-Hours: 20:00
Neuphoria Therapeutics EPS Diluted (Quarterly) : -0.0933 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.0933 |
| December 31, 2025 | -0.7749 |
| September 30, 2025 | -4.411 |
| March 31, 2025 | 6.551 |
| December 31, 2024 | -1.234 |
| Date | Value |
|---|---|
| September 30, 2024 | -0.0035 |
| June 30, 2024 | -29.21 |
| March 31, 2024 | -33.98 |
| December 31, 2023 | -63.75 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.5051M |
| Total Expenses (Quarterly) | 0.5051M |
| Enterprise Value | 0.6508M |
| Earnings Yield | 34.12% |
| Operating Earnings Yield | 17.96% |
| Normalized Earnings Yield | 62.77 |